OurCrowd
Last updated: May 9, 2026
Jerusalem-based private market investing platform that gives accredited investors and institutions access to pre-vetted startups, late-stage companies, and funds. The business is a financial access and syndication platform rather than a proprietary deep-tech vendor.
Visit WebsiteCompany Overview
OurCrowd is a Jerusalem-based private market investing platform founded in 2013. Its current public positioning emphasizes access to exclusive and pre-vetted startups, late-stage companies, and top-tier funds, with a model built around accredited investors and institutional capital. In practice, the company sits between venture sourcing, syndication, and private-market administration rather than operating as a software company with a deep technical product moat.
The commercial appeal is straightforward: many investors want exposure to venture and growth-stage private markets without building a full in-house sourcing and diligence capability. OurCrowd packages deal access, underwriting, portfolio reporting, and syndication into a single platform, which makes it useful to family offices, wealthy individuals, and institutions that want curated exposure to innovation. That positioning is strongest when markets are noisy and capital is selective, because the value of pre-vetted dealflow and a recognizable platform tends to rise when investors become more cautious.
The company's relevance to the Claw & Talon thesis is indirect but real. Israel produces a dense mix of cybersecurity, enterprise software, autonomy, sensing, and other security-relevant startups, and a platform like OurCrowd can surface that ecosystem for strategic readers who want structured exposure. That makes the business strategically interesting as a market-access node and a source of dealflow intelligence, even if the platform itself is not a defense technology developer.
At the same time, the company should be judged as a mature private-market intermediary. Its durability depends on regulatory execution, investor trust, sourcing quality, and the ability to keep relevant opportunities flowing through venture cycles. That is a different risk profile from a deep-tech startup with proprietary IP, and it means the most important diligence questions are about underwriting discipline, platform economics, and whether the firm can sustain differentiated access over time.
Strategic Fit Assessment
OurCrowd is strategically interesting as a private-market access platform, but it is not a compelling direct diligence target for a dual-use and deep-tech database. It is a mature private financial intermediary whose upside depends on marketplace economics, regulatory execution, and cyclical venture demand rather than proprietary technology or frontier IP.
Strategic Value to U.S.-Israel Alliance
The company is useful as a gateway to Israeli private innovation and as a source of dealflow intelligence, but its strategic value is access-oriented rather than product-led. It can help surface defense-adjacent opportunities, yet it should be treated as a financial infrastructure business, not as a defense or critical-technology platform.
Key Technologies
- Private market investment platform
- Accredited investor onboarding and compliance workflow
- Deal sourcing and diligence operations
- SPV and co-investment structuring
- Portfolio reporting and investor relations tooling
- Fund access and capital allocation infrastructure
- Cross-border private-market transaction support
Use Cases & Applications
- Accredited investor access to curated startup and growth deals
- Family office allocation to venture and private technology exposure
- Institutional co-investment alongside a platform sponsor
- Access to Israeli innovation without building an internal sourcing team
- Portfolio diversification across private-market opportunities
- Exposure to cybersecurity and other security-relevant technology themes
- Cross-border private-market investing and syndication
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- Official website Primary public reference for company identity, positioning, and current web presence.
- Profile update timestamp Last updated in the Claw & Talon database on May 9, 2026.
Investor Lens
What this entry is
Private startup
Why it may matter
OurCrowd may matter as a Cloud & Developer Infrastructure entry with not currently an investable standalone company for Israeli technology research.
How an independent investor should read this
Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.
Evidence to verify
- Verify current status
- Verify traction
- Verify cap table/funding
- Verify customer concentration
Main investor questions
- Is the company currently active, independently financeable, and raising or not raising on terms you can verify?
- What customer, revenue, product, and technical evidence supports the company story?
- What valuation, cap table, rights, and follow-on assumptions would govern any private exposure?
- What evidence would change the thesis or show that the profile is stale?
What not to infer
- Inclusion does not imply endorsement.
- Inclusion does not imply allocation availability or current fundraising.
- Scores do not indicate investment suitability or expected returns.
- Strategic importance does not automatically imply venture return potential.
Diligence questions
- What evidence verifies OurCrowd's current customer traction, deployment status, and revenue concentration?
- Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
- Is there a credible national-security or public-sector use case, or is the company primarily a commercial technology asset?
- What regulatory, procurement, and buyer-adoption constraints could slow deployment in strategic or government-adjacent markets?
- Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?
Related sector
See the Cloud & Developer Infrastructure sector page for market context, related subcategories, and other Israeli companies in this part of the database.
Related companies
Need a diligence readout?
Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.